Miltenyi Biotec Relocates-Expands Gaithersburg, Maryland, Headquarters
The company will expand its facility on 1201 Clopper Road to support additional manufacturing, research and development, quality assurance, and more. The expansion will bring the total number of employees to 300 in the state.
“Miltenyi Biotec’s decision to make Maryland its North American home is a testament to the strength of our life sciences industry as well as the supportive business climate we’ve established in our state,” said Maryland Commerce Secretary Mike Gill. “We’re thrilled the company has chosen to expand and create more good jobs in Maryland.”
To assist with job creation, the company has submitted a notice of intent to utilize the state’s More Jobs for Marylanders program and Job Creation Tax Credit, both managed by the Maryland Department of Commerce.
“The Montgomery County life sciences ecosystem encompasses a full range of biotech companies, including leading vector manufacturers like Miltenyi Biotec,” said Benjamin H. Wu, president & CEO of Montgomery County Economic Development Corporation. “Miltenyi Biotec is a global company on the rise, and we are delighted that they will continue advancing biomedical research and supporting cell and gene therapy from their Gaithersburg location.”
For more than 30 years, Miltenyi Biotec has focused on providing innovative products and services to support research throughout the biomedical and cellular therapy fields. With its global headquarters in Germany, Miltenyi Biotec has locations throughout Europe, Asia, Australia, and North America, and distributes its products to more than 50 countries. The company currently employs about 4,000 individuals around the world.
2023's Leading Metro Locations: Hotspots of Economic Growth
The Logistics Analysis That Drives Industrial Site Selection
2023 Top States for Doing Business Meet the Needs of Site Selectors
Technology’s Influence on Workforce Development
Workforce Q4 2023
AI 101 for Site Selection
First Person: Realizing the Inflation Reduction Act’s Full Potential
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects